Imvaq Therapeutics

Imvaq Therapeutics is a company that develops cancer immunotherapy solutions. It offers viral-based, armed immune-stimulating therapies for treating solid tumors including skin cancers, sarcoma, and triple-negative breast cancer. The company provides a Vaccinia Immunotherapy Platform with transgene insertion capacity and a species safety record.